United Therapeutics
UTHR
416 hedge funds and large institutions have $9.19B invested in United Therapeutics in 2021 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 139 increasing their positions, 160 reducing their positions, and 57 closing their positions.
145% more call options, than puts
Call options by funds: $46.1M | Put options by funds: $18.8M
13% more funds holding in top 10
Funds holding in top 10: 15 → 17 (+2)
13% more capital invested
Capital invested by funds: $8.15B → $9.19B (+$1.05B)
5% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 57
2% less funds holding
Funds holding: 425 → 416 (-9)
2.58% less ownership
Funds ownership: 98.56% → 95.98% (-2.6%)
13% less repeat investments, than reductions
Existing positions increased: 139 | Existing positions reduced: 160
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$189M |
| 2 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$84.8M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$63M |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$49.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$39.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$162M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$103M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$68.7M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$65.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$39.8M |
UTHR Hedge Fund Activity: Q4 2021 in Review
416 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2021, worth a combined $9.19B — up 13% from $8.15B a quarter earlier.
Sellers outnumbered buyers: 57 funds closed out of UTHR and 54 opened new positions — a net loss of 3 holders — while 160 trimmed existing stakes and 139 added.
The largest buyer was Wellington Management Group, adding an estimated $189M. The largest seller was Deutsche Bank, cutting an estimated $162M.
- 416 institutional investors held United Therapeutics (UTHR) as of Q4 2021, down from 425 in Q3 2021.
- Funds reported $9.19B of United Therapeutics stock for Q4 2021, up 13% quarter-over-quarter.
- 54 funds opened new United Therapeutics positions in Q4 2021 and 57 closed out, a net change of -3 holders.
- The largest United Therapeutics buyer in Q4 2021 was Wellington Management Group, an estimated $189M added.
- The largest United Therapeutics seller in Q4 2021 was Deutsche Bank, an estimated $162M sold.
Based on aggregated 13F filings for Q4 2021.